Mundipharma International
Manufacturing · United Kingdom · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Cambridge Science Park, Milton Road, Cam...Phone Number
+44 1223424211Website
www.mundipharma.comRevenue
$1.9 BillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
1
2
1
1
1
About Mundipharma International
Mundipharma International is a pharmaceutical company that develops partnerships with a wide range of pharmaceutical and biotech companies around Europe and the rest of the world. Mundipharma engages in the research and development of pain, oncology, inflammatory, and respiratory disease treatments for patients. Mundipharma International is based in the United Kingdom.Explore more
Mundipharma International Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mundipharma International your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Mundipharma International is spiking on competitors!
Check if Mundipharma International has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Mundipharma International had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Mundipharma International
Mundipharma International, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Mundipharma International has new funding data
Product Launch: Get notified when Mundipharma International launches new products
Earning: See what the market has to say on Mundipharma International recently announced quarterly report
Recommended Actions
Find VP level buyers at Mundipharma International
Find more new buyers
Compare Similar Companies to Mundipharma International
Compare insights from companies similar to Mundipharma International, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$5.7B
10K+
Public
-
1994
AH
Ai-Min HuiExecutive President of Fosun Pharma. President of Global Research and Development, Chief Marketing Officer and Chair of Scientific Committee
Company Profile Activity
Activity Insights
Mundipharma International is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Mundipharma International is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Mundipharma International.
Mundipharma International Tech Stack
A closer look at the technologies used by Mundipharma International
See more technologies
Most Recent Scoops
Open Position
Open Position
Hiring Plans
Mundipharma International has more open roles in Medical & Health than it has had at any time in the past 6 months.
Hiring Plans
Open Position
Open Position
Mundipharma International News & Media
Mundipharma acquires all assets and rights related to REZZAYO® (rezafungin), reinforcing continued commitment to management of infectious diseases and specialty care therapeutic area
CAMBRIDGE, England--(BUSINESS WIRE)--Mundipharma* today announced the acquisition of all assets and rights related to rezafungin globally from Cidara Therapeutics. This provides Mundipharma with global ownership of rezafungin including ongoing development and distribution. Rezafungin is a novel once-weekly echinocandin indicated for the treatment of invasive candidiasis in adults.1 Invasive candidiasis, is a severe, life-threatening infection of the bloodstream and/or deep/visceral tissues.2,3Mundipharma and Vectura announce plans to reformulate flutiform® (fluticasone propionate/formoterol fumarate) pressurised metered-dose inhaler (pMDI) as a commitment to reducing the product’s carbon footprint
CAMBRIDGE, England--(BUSINESS WIRE)--Mundipharma and Vectura will now progress development of the reformulation of flutiform® (fluticasone propionate/formoterol fumarate) following long-term collaboration, planning and lab-scale development work. The reformulation will ultimately ensure a comparable effective product for patients and further reduce its impact on the environment. The product is an established pressurised metered-dose inhaler (pMDI) for the treatment of asthma, where the use of aMundipharma announces European approval of REZZAYO® (rezafungin) for the treatment of Invasive Candidiasis in adults
CAMBRIDGE, England--(BUSINESS WIRE)--Mundipharma today announced rezafungin (rezafungin acetate) has been approved in the European Union (EU) for the treatment of invasive candidiasis in adults. The approval by the European Commission (EC) follows the positive opinion of the Committee for Medicinal Products for Human Use (CHMP) and is based on results from the pivotal ReSTORE Phase III clinical trial, which demonstrated statistical non-inferiority* for rezafungin, dosed once weekly, when comparMundipharma and Cidara Therapeutics receive positive CHMP opinion for rezafungin for the treatment of Invasive Candidiasis in adults1
CAMBRIDGE, England & SAN DIEGO--(BUSINESS WIRE)--Mundipharma and Cidara Therapeutics (Nasdaq: CDTX) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for rezafungin (rezafungin acetate) for the treatment of invasive candidiasis in adults.1 The CHMP based its positive opinion on results from the pivotal ReSTORE Phase III clinical trial, which demonstrated statistical non-inferiority* for rezafungin, dos
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mundipharma International
Sign Up For FreeTo access detailed company insights
Mundipharma International is a pharmaceutical company that develops partnerships with a wide range of pharmaceutical and biotech companies around Europe and the rest of the world. Mundipharma engages in the research and development of pain, oncology, inflammatory, and respiratory disease treatments for patients. Mundipharma International is based i... Read More
